Cargando…
TMEM16A as a potential treatment target for head and neck cancer
Transmembrane protein 16A (TMEM16A) forms a plasma membrane-localized Ca(2+)-activated Cl- channel. Its gene has been mapped to an area on chromosome 11q13, which is amplified in head and neck squamous cell carcinoma (HNSCC). In HNSCC, TMEM16A overexpression is associated with not only high tumor gr...
Autores principales: | Okuyama, Kohei, Yanamoto, Souichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172006/ https://www.ncbi.nlm.nih.gov/pubmed/35668455 http://dx.doi.org/10.1186/s13046-022-02405-2 |
Ejemplares similares
-
Tumor microenvironmental modification by the current target therapy for head and neck squamous cell carcinoma
por: Okuyama, Kohei, et al.
Publicado: (2023) -
Relationship between Tumor Budding and Partial Epithelial–Mesenchymal Transition in Head and Neck Cancer
por: Okuyama, Kohei, et al.
Publicado: (2023) -
Prolonged cetuximab treatment promotes p27(Kip1)-mediated G1 arrest and autophagy in head and neck squamous cell carcinoma
por: Okuyama, Kohei, et al.
Publicado: (2021) -
Cell-in-cell structure in cancer: evading strategies from anti-cancer therapies
por: Okuyama, Kohei, et al.
Publicado: (2023) -
ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer
por: Bill, Anke, et al.
Publicado: (2015)